Taxotere

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Breast CancerAdvanced Solid TumorsSmall Cell Lung Cancer

744 competitors in Breast Cancer

#DrugCompanyPhaseTrials

1

Taxotere

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3

182

Lexiscan

Astellas

Preclinical

13

Zolymbus

AbbVie

Preclinical

14

Blenoxane

Bristol-Myers Squibb

Preclinical

15

Spravato

WWim Janssens

Preclinical

26

Sporanox

SSebela Pharmaceuticals Development LLC

Preclinical

17

Acupan

YYonsei University

Preclinical

18

Chantix

PPrism Pharmaceuticals

Preclinical

19

Nubain

AAultman Health Foundation

Preclinical

110

Feraheme

AAzurity Pharmaceuticals

Preclinical

1Show 26 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Breast Cancer18 trials

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer

Completed·NNSABP Foundation Inc·Phase 2·NCT00003352·89 enrolled

Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer

Completed·Pfizer·Phase 3·NCT00393939·594 enrolled

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Recruiting·HH. Lee Moffitt Cancer Center and Research Institute·Phase 2·NCT06409390·15 enrolled

Show 15 more trials

Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer

Completed·Pfizer·Phase 1·NCT00291577·22 enrolled

A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)

Completed·Pfizer·Phase 3·NCT02187744·226 enrolled

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

Recruiting·JJina Pharmaceuticals Inc.·Phase 3·NCT03671044·657 enrolled

Adj TC + Herceptin Early Stage Breast Cancer

Completed·UUS Oncology Research·Phase 2·NCT00493649·493 enrolled

Breast Cancer Treated by Neoadjuvant Chemotherapy

Completed·CCentre Jean Perrin·Phase 2·NCT00425516·264 enrolled

XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Completed·Roche·Phase 4·NCT00127933·157 enrolled

A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer

Completed·Roche·Phase 2·NCT02748213·225 enrolled

Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer

Completed·EEric Winer, MD·Phase 2·NCT00148668·81 enrolled

Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer

Terminated·BBaylor Breast Care Center·Phase 2·NCT00206453·25 enrolled

A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer

Not yet recruiting·CSPC ZhongQi Pharmaceutical Technology Co., Ltd.·Phase 2·NCT07083505·60 enrolled

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive

Completed·Pfizer·Phase 1·NCT00372424·26 enrolled

Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients

Completed·SSpanish Breast Cancer Research Group·Phase 1/2·NCT00129896·73 enrolled

Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

Terminated·SSamyang Biopharmaceuticals Corporation·Phase 3·NCT05207514·26 enrolled

A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer

Completed·Roche·Phase 3·NCT00089479·2,611 enrolled

Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer

Terminated·CCentre Jean Perrin·Phase 2·NCT00852332·42 enrolled

Prostate Cancer10 trials

Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer

Completed·UUniversity of Louisville·Phase 1/2·NCT00456989·39 enrolled

PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer

Recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS··NCT06652607·152 enrolled

Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

Completed·Pfizer·Phase 2·NCT00031187·160 enrolled

Show 7 more trials

Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)

Terminated·CCentre Jean Perrin·Phase 2·NCT02095717·50 enrolled

Study of Oxaliplatin and Taxotere in Prostate Cancer

Completed·UUniversity of Pittsburgh·Phase 2·NCT00260611·34 enrolled

Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer

Unknown status·GGustave Roussy, Cancer Campus, Grand Paris·Phase 3·NCT02044354·195 enrolled

Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation

Completed·SStanford University·Phase 2·NCT00186420·13 enrolled

Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer

Completed·CCentre Antoine Lacassagne·Phase 2·NCT01796028·100 enrolled

Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)

Withdrawn·MM.D. Anderson Cancer Center·Phase 2·NCT00811031

A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer

Unknown status·DDepartment of Veterans Affairs, New Jersey·Phase 2·NCT00215345·66 enrolled

Gastric Cancer4 trials

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Unknown status·CSPC ZhongQi Pharmaceutical Technology Co., Ltd.·Phase 2·NCT05705635·100 enrolled

Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.

Suspended·HHokkaido Gastrointestinal Cancer Study Group·Phase 1/2·NCT00209729·50 enrolled

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Recruiting·CSPC ZhongQi Pharmaceutical Technology Co., Ltd.·Phase 3·NCT06296706·630 enrolled

Show 1 more trial

Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer

Completed·—·Phase 2·NCT00165464·54 enrolled

Squamous Cell Carcinoma3 trials

Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck

Completed·—·Phase 1/2·NCT00139243·30 enrolled

Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Completed·—·Phase 2·NCT00139230·30 enrolled

Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck

Terminated·UUniversity of Southern California·Phase 2·NCT00184028·12 enrolled

Esophageal Cancer3 trials

Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer

Completed·UUniversity of Alabama at Birmingham·Phase 2·NCT00318903·25 enrolled

Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.

Completed·HHokkaido Gastrointestinal Cancer Study Group·Phase 1/2·NCT00209690·30 enrolled

Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.

Completed·HHokkaido Gastrointestinal Cancer Study Group·Phase 1/2·NCT00209716·30 enrolled

21 more indications

Advanced Solid Cancer2 trials

Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer

Completed·SSamyang Biopharmaceuticals Corporation·Phase 1·NCT02274610·18 enrolled

Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer

Completed·SSamyang Biopharmaceuticals Corporation·Phase 1·NCT01336582·42 enrolled

Non-Small Cell Lung Cancer2 trials

A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)

Unknown status·CSPC ZhongQi Pharmaceutical Technology Co., Ltd.·Phase 2·NCT05863325·80 enrolled

Non-small Cell Lung Cancer Study US75 (Z-PACT)

Completed·Novartis·Phase 3·NCT00086268·250 enrolled

Pancreatic Cancer2 trials

Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer

Completed·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 1/2·NCT02324543·47 enrolled

Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer

Completed·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 2·NCT01459614·44 enrolled

Small Cell Lung Cancer2 trials

Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer

Completed·UUniversity Hospital, Limoges·Phase 3·NCT00284778·150 enrolled

Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

Completed·GGroupe Francais De Pneumo-Cancerologie··NCT00418704·100 enrolled

Tics1 trial

The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere

Unknown status·CSPC ZhongQi Pharmaceutical Technology Co., Ltd.·Phase 1·NCT04811118·27 enrolled

Chemotherapy1 trial

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

Completed·YYung Shin Pharm. Ind. Co., Ltd.··NCT02972216·40 enrolled

Patients With Advanced Solid Tumors1 trial

Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors

Completed·UUniversity of Arizona·Phase 1·NCT01172028·33 enrolled

Neoadjuvant Chemotherapy1 trial

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy

Unknown status·JJilin University·Phase 2·NCT02953184·160 enrolled

Advanced Solid Tumors1 trial

A Study of QLM2011 in Subjects With Advanced Solid Tumors

Not yet recruiting·QQilu Pharmaceutical (Hainan) Co., Ltd.·Phase 1·NCT06925659·172 enrolled

Efficacy and Safety1 trial

Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy

Terminated·UUniversity of Massachusetts, Worcester·Phase 1·NCT00424840·12 enrolled

Concurrent Chemoradiotherapy1 trial

Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors

Withdrawn·SShin Kong Wu Ho-Su Memorial Hospital·Phase 2·NCT02120118

Esophageal Carcinoma1 trial

Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma

Terminated·AArbeitsgemeinschaft medikamentoese Tumortherapie·Phase 2·NCT00735345·50 enrolled

Head and Neck Cancer1 trial

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Completed·—·Phase 1·NCT00006107·31 enrolled

Recurrent Head and Neck Cancer1 trial

Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer

Unknown status·SShin Kong Wu Ho-Su Memorial Hospital·Phase 2·NCT02567383·45 enrolled

Neoadjuvant1 trial

Neoadjuvant Taxotere

Completed·BBaylor Breast Care Center·Phase 2·NCT00206505·40 enrolled

Head and Neck Carcinoma1 trial

Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma

Terminated·UUniversity of Miami·Phase 2·NCT01794845·5 enrolled

Bladder Cancer1 trial

Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer

Completed·SStanford University·Phase 2·NCT00186277·10 enrolled

Squamous Cell Cancer of the Head and Neck1 trial

Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck

Completed·—·Phase 1·NCT00003200·22 enrolled

Solid Tumor Malignancies1 trial

Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies

Completed·—·Phase 1·NCT00251407·46 enrolled

Lung Cancer1 trial

TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer

Terminated·—·Phase 3·NCT01282151·148 enrolled

Unspecified2 trials

Biologic Correlative Taxotere/AC

Completed·BBaylor Breast Care Center·Phase 2·NCT00206466·70 enrolled

Multi-academic Center Study of Xofigo Patients

Completed·Bayer··NCT03419442·150 enrolled

Details

Drug Info

Related News